Engineers Gate Manager LP Lowers Holdings in Tenet Healthcare Corporation $THC

Engineers Gate Manager LP cut its position in Tenet Healthcare Corporation (NYSE:THC) by 23.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 94,826 shares of the company’s stock after selling 29,504 shares during the quarter. Engineers Gate Manager LP’s holdings in Tenet Healthcare were worth $18,844,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of THC. Triumph Capital Management purchased a new stake in Tenet Healthcare in the 3rd quarter worth approximately $25,000. Activest Wealth Management bought a new position in shares of Tenet Healthcare in the 4th quarter worth $26,000. Elyxium Wealth LLC bought a new position in shares of Tenet Healthcare in the 4th quarter worth $29,000. Canada Pension Plan Investment Board bought a new position in shares of Tenet Healthcare in the 2nd quarter worth $35,000. Finally, Meeder Asset Management Inc. increased its holdings in shares of Tenet Healthcare by 146.2% in the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after buying an additional 114 shares during the last quarter. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director J Robert Kerrey sold 5,638 shares of the firm’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the sale, the director directly owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Nadja West sold 3,000 shares of the firm’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total transaction of $532,050.00. Following the completion of the sale, the director directly owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. This represents a 10.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.97% of the company’s stock.

Tenet Healthcare Trading Down 2.7%

Shares of THC opened at $178.63 on Thursday. The stock has a market capitalization of $15.39 billion, a P/E ratio of 9.29, a PEG ratio of 1.51 and a beta of 1.28. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. The firm has a fifty day simple moving average of $183.44 and a two-hundred day simple moving average of $199.04. Tenet Healthcare Corporation has a twelve month low of $146.60 and a twelve month high of $247.21.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, beating the consensus estimate of $4.21 by $0.61. The business had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, research analysts anticipate that Tenet Healthcare Corporation will post 17.61 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Wall Street Zen lowered shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, May 11th. Leerink Partners increased their price target on shares of Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a report on Friday, February 20th. KeyCorp decreased their price target on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Stephens decreased their price target on shares of Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating on the stock in a report on Monday, May 4th. Finally, Morgan Stanley set a $254.00 target price on shares of Tenet Healthcare in a report on Friday, May 1st. Eighteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $244.16.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.